Sinovac Biotech Ltd SEC filings SVA
Sinovac Biotech Ltd has 578 filings in SEC EDGAR's recent list, going back to Jan 20, 2000. Its latest annual report, Form 20-F, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 17, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Jan 12, 2006 | Feb 16, 2006 |
Showing 1 filing. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Antigua and Barbuda
- Headquarters
- Beijing
- SEC filer status
- Accelerated filer
- SEC CIK
- 1084201
- Former names
- NET FORCE SYSTEMS INC (until Jan 13, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.